ABSTRACT Colombia introduced mass pneumococcal conjugate vaccination at the end of 2011. Using 2005–2015 surveillance data, we conducted a retrospective interrupted time-series analysis. A significant trend towards reduced monthly was observed in the post-vaccination period (2012–2015) compared with the expected rate, reaching in 2015 a reduction of 90.5% of pneumococcal meningitis. This trend was not observed for control diseases.
All Keywords
【저자키워드】 Meningitis, Colombia, pneumococcal conjugate vaccine,
【저자키워드】 Meningitis, Colombia, pneumococcal conjugate vaccine,